Inventor · disambiguated record
Jian Liu
Also filed as: LIU JIAN · LIU JIAN-NING
31 granted patents·36 pending applications·273 citations·filing 1993–2024
96Inventor score
Files withNITTO DENKO CORP9ETERNITY BIOSCIENCE INC8UNIV NORTH CAROLINA CHAPEL HILL8THROMBOLYTIC SCIENCE INC5NATIONWIDE CHILDRENS HOSPITAL INC4
Top patents by PatentIndex Score
67 records- 0193US8003621B2Drug carriersNITTO DENKO CORP·Filed 2008·Granted Aug 23, 2011·33 cites·26 claims
- 0293US7442682B2Transepithelial delivery of peptides with incretin hormone activitiesNITTO DENKO CORP·Filed 2005·Granted Oct 28, 2008·66 cites·29 claims
- 0389US9951149B2Reversible heparin molecules and methods of making and using the sameUNIV NORTH CAROLINA CHAPEL HILL·Filed 2014·Granted Apr 24, 2018·17 cites·21 claims
- 0489US8771995B2Enzymatic synthesis of sulfated polysaccharidesLIU JIAN·Filed 2012·Granted Jul 8, 2014·13 cites·6 claims
- 0589US8309514B2Peptide nucleic acid based guanidinium compoundsZHAO GANG·Filed 2010·Granted Nov 13, 2012·9 cites·15 claims
- 0687US9469851B2Recombinant virus products and methods for inhibition of expression of DUX4HARPER SCOTT QUENTON·Filed 2012·Granted Oct 18, 2016·14 cites·5 claims
- 0786US11633424B2Cell protective methods and compositionsUNIV NORTH CAROLINA CHAPEL HILL·Filed 2019·Granted Apr 25, 2023·7 cites·13 claims
- 0886US10301649B2Recombinant virus products and methods for inhibition of expression of DUX4NATIONWIDE CHILDRENS HOSPITAL INC·Filed 2016·Granted May 28, 2019·7 cites·2 claims
- 0986US9133482B2Recombinant virus products and methods for inhibition of expression of myotilinHARPER SCOTT QUENTON·Filed 2013·Granted Sep 15, 2015·6 cites·3 claims
- 1083US11993627B2Enzymatic synthesis of homogeneous chondroitin sulfate oligosaccharidesUNIV NORTH CAROLINA CHAPEL HILL·Filed 2018·Granted May 28, 2024·3 cites·8 claims
- 1183US11865137B2Sulfated oligosaccharides having anti-inflammatory activityUNIV NORTH CAROLINA CHAPEL HILL·Filed 2018·Granted Jan 9, 2024·3 cites·24 claims
- 1282US11203772B2Chemoenzymatic synthesis of structurally homogeneous ultra-low molecular weight heparinsXU YONGMEI·Filed 2011·Granted Dec 21, 2021·7 cites·3 claims
- 1382US7745392B2Multi-valent guanidinium compounds for enhancing molecular translocation across cellular membranes and epithelial tissuesNITTO DENKO CORP·Filed 2006·Granted Jun 29, 2010·2 cites·22 claims
- 1481US7687603B2Guanidinium delivery carriersNITTO DENKO CORP·Filed 2006·Granted Mar 30, 2010·5 cites·7 claims
- 1580US11903963B2Short-acting heparin-based anticoagulant compounds and methodsUNIV NORTH CAROLINA CHAPEL HILL·Filed 2018·Granted Feb 20, 2024·3 cites·44 claims
- 1680US11802291B2Recombinant virus products and methods for inhibition of expression of DUX4RES INST NATIONWIDE CHILDRENS HOSPITAL·Filed 2019·Granted Oct 31, 2023·1 cites·10 claims
- 1779US7531338B2Purified and isolated heparan sulfate 3-O-sulfotransferase isoform 5 nucleic acids and polypeptides and therapeutic and screening methods using sameUNIV NORTH CAROLINA·Filed 2003·Granted May 12, 2009·12 cites·4 claims
- 1879US7074401B2Methods, devices, and compositions for lysis of occlusive blood clots while sparing wound sealing clotsTHROMBOLYTIC SCIENCE INC·Filed 2004·Granted Jul 11, 2006·11 cites·6 claims
- 1978US2024318201A1Recombinant virus products and methods for inhibition of expression of dux4RES INSTITUTE AT NATIONWIDE CHILDREN’S HOSPITAL·Filed 2023·Application pending·0 cites
- 2077US5472692APro-urokinase mutantsNEW ENGLAND DEACONESS HOSPITAL·Filed 1993·Granted Dec 5, 1995·52 cites·9 claims
- 2176US12325856B2Recombinant virus products and methods for inhibition of expression of myotilinNATIONWIDE CHILDRENS HOSPITAL INC·Filed 2021·Granted Jun 10, 2025·0 cites·10 claims
- 2275US10196636B2Recombinant virus products and methods for inhibition of expression of myotilinNATIONWIDE CHILDRENS HOSPITAL INC·Filed 2015·Granted Feb 5, 2019·1 cites·20 claims
- 2375US7700565B2Peptide nucleic acid based guanidinium compoundsNITTO DENKO CORP·Filed 2006·Granted Apr 20, 2010·1 cites·10 claims
- 2475US2024309035A1Enzymatic synthesis of homogeneous chondroitin sulfate oligosaccharidesUNIV NORTH CAROLINA CHAPEL HILL·Filed 2024·Application pending·0 cites
- 2571US12397016B2Sulfated oligosaccharides having anti-inflammatory activityUNIV NORTH CAROLINA CHAPEL HILL·Filed 2024·Granted Aug 26, 2025·0 cites·8 claims
- 2669US11091760B2Recombinant virus products and methods for inhibition of expression of myotilinNATIONWIDE CHILDRENS HOSPITAL INC·Filed 2018·Granted Aug 17, 2021·0 cites·10 claims
- 2767US2024263196A1Lipid Compositions and Methods for Delivery to Immune CellsLIFE TECHNOLOGIES CORP·Filed 2023·Application pending·0 cites
- 2865US2023277580A1Cell protective methods and compositionsUNIV NORTH CAROLINA CHAPEL HILL·Filed 2023·Application pending·0 cites
- 2964US2009136557A1Methods, Devices, And Compositions For Lysis Of Occlusive Blood Clots While Sparing Wound Sealing ClotsTHROMBOLYTIC SCIENCE INC·Filed 2008·Application pending·0 cites
- 3063US2009226413A1Methods, Devices, And Compositions For Lysis Of Occlusive Blood Clots While Sparing Wound Sealing ClotsTHROMBOLYTIC SCIENCE INC·Filed 2008·Application pending·0 cites
- 3162US2025320202A1Prmt5 inhibitor, preparation method therefor, and pharmaceutical use thereofABBISKO THERAPEUTICS CO LTD·Filed 2023·Application pending·0 cites
- 3262US2009226410A1Methods, Devices, And Compositions For Lysis Of Occlusive Blood Clots While Sparing Wound Sealing ClotsTHROMBOLYTIC SCIENCE INC·Filed 2008·Application pending·0 cites
- 3360US2024408088A1Pyrazole derivative, and preparation method therefor and use thereof in medicineABBISKO THERAPEUTICS CO LTD·Filed 2022·Application pending·0 cites
- 3459US2025177573A1Materials & Methods for Treatment of Macular DegenerationUNIV BRISTOL·Filed 2022·Application pending·0 cites
- 3557US2007148160A1Methods, devices, and compositions for lysis of occlusive blood clots while sparing wound sealing clotsTHROMBOLYTIC SCIENCE INC·Filed 2006·Application pending·0 cites
- 3656US2022331427A1Non-invasive near-infrared light-controlled nanomaterial for treatment of diabetesUNIV SOOCHOW·Filed 2020·Application pending·0 cites
- 3754US2022135539A1Biaryl amide compounds, preparation methods and medical applications thereofETERNITY BIOSCIENCE INC·Filed 2021·Application pending·0 cites
- 3854US2022144842A1Irak inhibitors, preparation method and medicinal uses thereofETERNITY BIOSCIENCE INC·Filed 2021·Application pending·0 cites
- 3954US2010234274A1Use of Nestafin-1 in the Treatment for DiabetesLIU JIAN-NING·Filed 2009·Application pending·0 cites
- 4054US2022177446A1Alkyne compounds as irak inhibitors, preparation methods and medicinal uses thereofETERNITY BIOSCIENCE INC·Filed 2021·Application pending·0 cites
- 4154US2022213086A1Azole compounds as irak inhibitors, preparation methods and medicinal uses thereofETERNITY BIOSCIENCE INC·Filed 2021·Application pending·0 cites
- 4253US12441716B2Compositions and methods for increasing muscle mass and oxidative metabolismUNIV CALIFORNIA·Filed 2020·Granted Oct 14, 2025·0 cites·5 claims
- 4353US2009035787A1Enzymatic synthesis of sulfated polysaccharides without iduronic acid residuesUNIV NORTH CAROLINA·Filed 2008·Application pending·0 cites
- 4453US2024325521A1Ionizable lipid compound for nucleic acid delivery and lnp composition thereofJENKEM TECH CO LTD TIANJIN·Filed 2022·Application pending·0 cites
- 4553US2008312174A1Water soluble crosslinked polymersNITTO DENKO CORP·Filed 2008·Application pending·0 cites
- 4652US2009197308A1Enzymatic synthesis of sulfated polysaccharidesLIU JIAN·Filed 2006·Application pending·0 cites
- 4752US2022333094A1Method for preparing cell membrane-coated nano topologicalarray and use thereofUNIV SOOCHOW·Filed 2021·Application pending·0 cites
- 4851US2012093762A1Nucleic acid delivery compoundsCHIVAKULA PADMANABH·Filed 2011·Application pending·0 cites
- 4951US2012094924A1Nucleic acid delivery compoundsCHIVUKULA PADMANABH·Filed 2011·Application pending·0 cites
- 5050US2013011336A1Imaging agents of fibrotic diseasesNITTO DENKO CORP·Filed 2009·Application pending·0 cites
Showing the top 50 of 67 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Jian Liu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →